Exploring the mechanism of plastic additives on reproductive disorders based on network toxicology and molecular docking

other OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-06-13

This study used network toxicology and molecular docking to identify shared and disease-specific molecular targets of phthalates and organophosphates linked to polycystic ovary syndrome, recurrent pregnancy loss, and endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-13 · read from full text

This study used an integrative network toxicology approach combining molecular docking, network pharmacology, and multi-omics analysis to characterize how phthalate esters (PAEs) and organophosphate esters (OPEs) might mechanistically contribute to female reproductive disorders, focusing on polycystic ovary syndrome (PCOS), recurrent pregnancy loss (RPL), and endometriosis. The authors identified disease-specific hub genes—ESR1 and MMP9 for PCOS, CTNNB1 and BCL2 for RPL, and IL6 and NFKB1 for endometriosis—and reported shared pathways including NF-κB activation, PI3K-AKT dysregulation, and microRNA-mediated regulation; molecular docking supported direct binding of DEHP, MEHP, and TPHP to key hub targets, and gene-based diagnostic nomograms produced AUCs of 0.72–0.94. A major caveat noted implicitly by the design is that conclusions rely on in silico network analyses and docking rather than experimental validation in patient samples. Relevance to endometriosis: endometriosis is one of the three disorders analyzed, with hub genes IL6 and NFKB1 and shared mechanisms such as NF-κB activation used to link PAE/OPE exposure to endometriosis-specific molecular targets.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Phthalate esters (PAEs) and organophosphate esters (OPEs) are pervasive 20 environmental pollutants with endocrine-disrupting properties. Despite growing 21 evidence linking PAE/OPE exposure to female reproductive disorders, the 22 diseasespecific molecular targets and cross-disease mechanistic convergence in 23 polycystic ovary syndrome (PCOS), recurrent pregnancy loss (RPL), and 24 endometriosis remain undefined. We employed an integrative network toxicology 25 framework combining molecular docking, network pharmacology, multi-omics 26 analysis to systematically elucidate PAE/OPE-target interactions across three 27 clinically interrelated reproductive disorders. Our analysis identified disease-specific28 hub genes, ESR1 and MMP9 for PCOS, CTNNB1 and BCL2 for RPL, and IL6 and 29 NFKB1 for endometriosis, along with shared pathogenic mechanisms including 30 NF-κB activation, PI3K-AKT dysregulation, and microRNA-mediated regulation. 31 Molecular docking confirmed direct binding of DEHP, MEHP, and TPHP to key hub32 targets. Diagnostic nomograms integrating hub genes achieved AUCs of 0.72-0.94, 33 suggesting their potential as biomarkers for risk stratification. This study provides a 34 cross-disease network framework linking PAE/OPE exposure to female reproductive35 toxicity, offering mechanistic insights and candidate biomarkers for risk assessment 36 and targeted prevention strategies.
Full text 1,717 characters · extracted from oa-doi-fallback · click to expand
Abstract Phthalate esters (PAEs) and organophosphate esters (OPEs) are pervasive 20 environmental pollutants with endocrine-disrupting properties. Despite growing 21 evidence linking PAE/OPE exposure to female reproductive disorders, the 22 diseasespecific molecular targets and cross-disease mechanistic convergence in 23 polycystic ovary syndrome (PCOS), recurrent pregnancy loss (RPL), and 24 endometriosis remain undefined. We employed an integrative network toxicology 25 framework combining molecular docking, network pharmacology, multi-omics 26 analysis to systematically elucidate PAE/OPE-target interactions across three 27 clinically interrelated reproductive disorders. Our analysis identified disease-specific28 hub genes, ESR1 and MMP9 for PCOS, CTNNB1 and BCL2 for RPL, and IL6 and 29 NFKB1 for endometriosis, along with shared pathogenic mechanisms including 30 NF-κB activation, PI3K-AKT dysregulation, and microRNA-mediated regulation. 31 Molecular docking confirmed direct binding of DEHP, MEHP, and TPHP to key hub32 targets. Diagnostic nomograms integrating hub genes achieved AUCs of 0.72–0.94, 33 suggesting their potential as biomarkers for risk stratification. This study provides a 34 cross-disease network framework linking PAE/OPE exposure to female reproductive35 toxicity, offering mechanistic insights and candidate biomarkers for risk assessment 36 and targeted prevention strategies. Disclosure statement No potential conflict of interest was reported by author(s). Data availability statement The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary Material.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Endocrine Disruptors Endocrine Disruptors Endocrine Disruptors Endocrine Disruptors Endocrine Disruptors Endocrine Disruptors Endocrine Disruptors Endocrine Disruptors Endocrine Disruptors Endocrine Disruptors Endocrine Disruptors Endocrine Disruptors Endocrine Disruptors Endocrine Disruptors Endocrine Disruptors Endocrine Disruptors Endocrine Disruptors Endocrine Disruptors Endocrine Disruptors Endocrine Disruptors

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

SciLite annotations

chemicals 2
phthalate ester selenite esters

Source provenance

europepmc
last seen: 2026-09-07T06:12:11.729357+00:00
pubmed
last seen: 2026-09-08T06:10:06.790093+00:00
scilite
last seen: 2026-06-21T06:47:03.627287+00:00
unpaywall
last seen: 2026-09-07T06:27:18.705824+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine